174 related articles for article (PubMed ID: 32618436)
41. Independent Assessment of the Children's Hepatic Tumors International Collaboration Risk Stratification for Hepatoblastoma and the Association of Tumor Histological Characteristics With Prognosis.
Zhou S; Malvar J; Chi YY; Stein J; Wang L; Genyk Y; Sposto R; Mascarenhas L
JAMA Netw Open; 2022 Feb; 5(2):e2148013. PubMed ID: 35147687
[TBL] [Abstract][Full Text] [Related]
42. Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study.
Katzenstein HM; London WB; Douglass EC; Reynolds M; Plaschkes J; Finegold MJ; Bowman LC
J Clin Oncol; 2002 Aug; 20(16):3438-44. PubMed ID: 12177104
[TBL] [Abstract][Full Text] [Related]
43. New concepts and outcomes for children with hepatoblastoma based on the experience of a tertiary center over the last 21 years.
Tannuri AC; Cristofani LM; Teixeira RA; Odone Filho V; Tannuri U
Clinics (Sao Paulo); 2015 Jun; 70(6):387-92. PubMed ID: 26106955
[TBL] [Abstract][Full Text] [Related]
44. Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94.
Fuchs J; Bode U; von Schweinitz D; Weinel P; Erttmann R; Harms D; Mildenberger H
Klin Padiatr; 1999; 211(4):305-9. PubMed ID: 10472567
[TBL] [Abstract][Full Text] [Related]
45. Phase II study of high-dose cyclophosphamide in relapsing and/or resistant hepatoblastoma in children: a study from the SIOPEL group.
Cacciavillano WD; Brugières L; Childs M; Shafford E; Brock P; Pritchard J; Mailbach R; Scopinaro M; Perilongo G
Eur J Cancer; 2004 Oct; 40(15):2274-9. PubMed ID: 15454253
[TBL] [Abstract][Full Text] [Related]
46. Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan.
Hsu WY; Chang HH; Lu MY; Yang YL; Jou ST; Chen HL; Ni YH; Hsu HY; Chang MH; Wu JF
Pediatr Neonatol; 2020 Aug; 61(4):393-398. PubMed ID: 32291200
[TBL] [Abstract][Full Text] [Related]
47. Surgical resection and chemotherapy improve survival rate for patients with hepatoblastoma.
Carceller A; Blanchard H; Champagne J; St-Vil D; Bensoussan AL
J Pediatr Surg; 2001 May; 36(5):755-9. PubMed ID: 11329582
[TBL] [Abstract][Full Text] [Related]
48. Treatment of hepatoblastoma: less extensive hepatectomy after effective preoperative chemotherapy with cisplatin and adriamycin.
Seo T; Ando H; Watanabe Y; Harada T; Ito F; Kaneko K; Horibe K; Sugito T; Ito T
Surgery; 1998 Apr; 123(4):407-14. PubMed ID: 9551066
[TBL] [Abstract][Full Text] [Related]
49. Multidisciplinary effort in treating children with hepatoblastoma in China.
Yuan XJ; Wang HM; Jiang H; Tang MJ; Li ZL; Zou X; Fang YJ; Pan C; Tou JF; Zhang KR; Liu X; Li WS; Li Y; Lu J; Wu YM
Cancer Lett; 2016 May; 375(1):39-46. PubMed ID: 26945966
[TBL] [Abstract][Full Text] [Related]
50. Is multifocality a prognostic factor in childhood hepatoblastoma?
Saettini F; Conter V; Provenzi M; Rota M; Giraldi E; Foglia C; Cavalleri L; D'Antiga L
Pediatr Blood Cancer; 2014 Sep; 61(9):1593-7. PubMed ID: 24757164
[TBL] [Abstract][Full Text] [Related]
51. Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss.
Brock PR; Maibach R; Childs M; Rajput K; Roebuck D; Sullivan MJ; Laithier V; Ronghe M; Dall'Igna P; Hiyama E; Brichard B; Skeen J; Mateos ME; Capra M; Rangaswami AA; Ansari M; Rechnitzer C; Veal GJ; Covezzoli A; Brugières L; Perilongo G; Czauderna P; Morland B; Neuwelt EA
N Engl J Med; 2018 Jun; 378(25):2376-2385. PubMed ID: 29924955
[TBL] [Abstract][Full Text] [Related]
52. Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report.
Aronson DC; Weeda VB; Maibach R; Czauderna P; Dall'Igna P; de Ville de Goyet J; Branchereau S; Perilongo G; Brock P; Zsiros J; Semeraro M; Chardot C; Wildhaber B; Morland B; Brugières L;
Eur J Cancer; 2019 Jan; 106():126-132. PubMed ID: 30528797
[TBL] [Abstract][Full Text] [Related]
53. Clinicopathological profile of hepatoblastoma: An experience from a tertiary care center in India.
Archana B; Thanka J; Sneha LM; Xavier Scott JJ; Arunan M; Agarwal P
Indian J Pathol Microbiol; 2019; 62(4):556-560. PubMed ID: 31611439
[TBL] [Abstract][Full Text] [Related]
54. Clinical risk factors for patients with ruptured hepatoblastoma in children: a retrospective study from a single center in China.
Chang S; Yang S; Yang W; Qin H; Cheng H; Chang X; Zhu Z; Yin J; Ren Q; Yu S; Wang H
Pediatr Surg Int; 2023 Jan; 39(1):76. PubMed ID: 36622431
[TBL] [Abstract][Full Text] [Related]
55. Survival and long-term outcomes in children with hepatoblastoma treated with continuous infusion of cisplatin and doxorubicin.
Sivaprakasam P; Gupta AA; Greenberg ML; Capra M; Nathan PC
J Pediatr Hematol Oncol; 2011 Aug; 33(6):e226-30. PubMed ID: 21792028
[TBL] [Abstract][Full Text] [Related]
56. Fibrolamellar hepatocellular carcinoma in children and adolescents.
Katzenstein HM; Krailo MD; Malogolowkin MH; Ortega JA; Qu W; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Newman K; Finegold MJ; Haas JE; Sensel MG; Castleberry RP; Bowman LC
Cancer; 2003 Apr; 97(8):2006-12. PubMed ID: 12673731
[TBL] [Abstract][Full Text] [Related]
57. Hepatoblastoma: an oncological review.
Roebuck DJ; Perilongo G
Pediatr Radiol; 2006 Mar; 36(3):183-6. PubMed ID: 16404556
[TBL] [Abstract][Full Text] [Related]
58. Liver transplantation for hepatoblastoma.
Faraj W; Dar F; Marangoni G; Bartlett A; Melendez HV; Hadzic D; Dhawan A; Mieli-Vergani G; Rela M; Heaton N
Liver Transpl; 2008 Nov; 14(11):1614-9. PubMed ID: 18975296
[TBL] [Abstract][Full Text] [Related]
59. [Clinical observation on the treatment outcome of 14 children with hepatoblastoma in a single medical center].
Pan C; Tang JY; Chen J; Xue HL; Dong L; Zhou M; Jiang H; Ye QD; Gu LJ
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Aug; 11(8):659-62. PubMed ID: 19695195
[TBL] [Abstract][Full Text] [Related]
60. Carboplatin and doxorubicin (CARDOX) for nonmetastatic hepatoblastoma: a discouraging pilot study.
Dall'Igna P; Cecchetto G; Dominici C; Donfrancesco A; Carli M; Indolfi P; Guglielmi M; Perilongo G
Med Pediatr Oncol; 2001 Feb; 36(2):332-4. PubMed ID: 11452948
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
